Pentcillin


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 20.8%
Infection 14.9%
Pneumonia 11.6%
Pancytopenia 7.6%
Product Used For Unknown Indication 5.9%
Pancreatitis 4.3%
Induction Of Anaesthesia 3.5%
Constipation 3.2%
Infection Prophylaxis 2.7%
Pemphigoid 2.7%
Urinary Tract Infection 2.7%
Fluid Replacement 2.4%
Gastric Ulcer 2.4%
Hypertension 2.4%
Pyrexia 2.4%
B-cell Lymphoma 2.2%
Febrile Neutropenia 2.2%
Rheumatoid Arthritis 2.2%
Anaesthesia Procedure 1.9%
Cerebral Infarction 1.9%
Renal Impairment 11.8%
Toxic Epidermal Necrolysis 10.3%
Tremor 7.4%
Hepatic Function Abnormal 5.9%
Pulmonary Congestion 5.9%
Renal Disorder 5.9%
Anaphylactic Shock 4.4%
Cardiac Output Decreased 4.4%
Interstitial Lung Disease 4.4%
Leukoencephalopathy 4.4%
Pneumonia 4.4%
Thrombocytopenia 4.4%
Wheezing 4.4%
Wound Dehiscence 4.4%
Acute Generalised Exanthematous Pustulosis 2.9%
Body Temperature Decreased 2.9%
Enterocolitis 2.9%
Prothrombin Level Decreased 2.9%
Rash Generalised 2.9%
Respiratory Arrest 2.9%
Concomitant
Prophylaxis 13.6%
Renal Transplant 12.8%
Pneumonia 12.1%
Hypertension 7.3%
Cancer Pain 7.0%
Cardiac Pacemaker Replacement 5.4%
Product Used For Unknown Indication 5.4%
Drug Use For Unknown Indication 4.0%
Infection Prophylaxis 3.8%
Infection 3.7%
Insomnia 2.9%
Sepsis 2.8%
Diabetes Mellitus 2.5%
Cerebral Palsy 2.4%
Mental Retardation Severity Unspecified 2.4%
Osteoporosis 2.4%
Thrombosis Prophylaxis 2.4%
Tonsillar Inflammation 2.4%
Acute Promyelocytic Leukaemia 2.3%
Allogenic Bone Marrow Transplantation Therapy 2.1%
White Blood Cell Count Decreased 13.1%
Platelet Count Decreased 11.1%
Urine Output Decreased 9.8%
Liver Disorder 6.5%
Renal Failure 4.6%
Shock 4.6%
Hepatic Encephalopathy 3.9%
Hepatic Function Abnormal 3.9%
Interstitial Lung Disease 3.9%
Pneumonia 3.9%
Pyrexia 3.9%
Staphylococcal Infection 3.9%
Toxic Epidermal Necrolysis 3.9%
Cardiac Failure 3.3%
Coagulation Test Abnormal 3.3%
Platelet Count Increased 3.3%
Respiratory Failure 3.3%
Sepsis 3.3%
Stupor 3.3%
Upper Gastrointestinal Haemorrhage 3.3%

Drug Data